Enteral nutrition in the treatment of inflammatory bowel disease

1. Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2015; 21: 1982–1992.

2. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015; 47: 979–986.

3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46–54.

4. Pozler O, Maly J, Bonova O, et al. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2006; 42: 186–189.

5. Schwarz J, Sýkora J. Incidence idiopatických střevních zánětů u dětí a dospívajících v Plzeňském kraji v letech 2001–2011 Prospektivní studie. Čes-slov Pediat 2013; 68 (3): 149–156.

6. Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 2017; 152: 313–321.

7. Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: A review. Dig Dis Sci 2015; 60: 290–298.

8. Abegunde AT, Muhammad BH, Bhatti O, et al. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol 2016; 22: 6296.

9. Lee D, Albenberg L, Compher C, et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 2015; 148: 1087–1106.

10. Chapman-Kiddell CA, Davies PSW, Gillen L, et al. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 137–151.

11. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014; 146: 1489–1499.

12. Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe 2015; 18: 489–500.

13. Levine A, Wine E. Effects of enteral nutrition on Crohn’s disease. Inflamm Bowel Dis 2013; 19: 1322–1329.

14. Burman S, Hoedt EC, Pottenger S, et al. An (anti)-inflammatory microbiota: Defining the role in inflammatory bowel disease? Dig Dis 2016; 34: 64–71.

15. Miyoshi J, Chang EB. The gut microbiota and inflammatory bowel diseases. Transl Res 2017; 179: 38–48.

16. Faith JJ, McNulty NP, Rey FE, et al. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science 2011; 333: 101–104.

17. Basson A, Trotter A, Rodriguez-Palacios A, et al. Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease. Front Immunol 2016; 7: 290.

18. Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohn Colitis 2014; 8: 1179–1207.

19. Adamcová M, Bajer M, Bajerová K, et al. Doporučení Pracovní skupiny dětské gastroenterologie a výživy ČPS pro diagnostiku a léčbu nespecifických střevních zánětů u dětí. Čes-slov Pediat 2012; 67: 3–48.

20. Levine A, Sladek M, Shaoul R, et al. P255 Exclusive enteral nutrition is superior to corticosteroids and mesalamine for achieving remission with normalization of CRP in new onset pediatric Crohn’s disease. J Crohn Colitis 2012; 6: S111.

21. Grover Z, Lewindon P. Two-year outcomes after exclusive enteral nutrition induction are superior to corticosteroids in pediatric Crohn’s disease treated early with thiopurines. Dig Dis Sci 2015; 60: 3069–3074.

22. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8–15.

23. Levine A, Turner D, Pfeffer Gik T, et al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn’s disease. Inflamm Bowel Dis 2014; 20: 278–285.

24. Day AS, Lopez RN. Exclusive enteral nutrition in children with Crohn’s disease. World J Gastroenterol 2015; 21: 6809–6816.

25. Gerasimidis K, Talwar D, Duncan A, et al. Impact of exclusive enteral nutrition on body composition and circulating micronutrients in plasma and erythrocytes of children with active Crohn’s disease. Inflamm Bowel Dis 2012; 18: 1672–1681.

26. Cameron FL, Gerasimidis K, Papangelou A, et al. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn’s disease. Aliment Pharmacol Ther 2013; 37: 622–629.

27. Borrelli O, Cordischi L, Cirulli M, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: A randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006; 4: 744–753.

28. Grover Z, Burgess C, Muir R, et al. Early mucosal healing with exclusive enteral nutrition is associated with improved outcomes in newly diagnosed children with luminal Crohn’s disease. J Crohn Colitis 2016; 10: 1159–1164.

29. Werkstetter KJ, Schatz SB, Alberer M, et al. Influence of exclusive enteral nutrition therapy on bone density and geometry in newly diagnosed pediatric Crohn’s disease patients. Ann Nutr Metab 2013; 63: 10–16.

30. Whitten KE, Leach ST, Bohane TD, et al. Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease. J Gastroenterol 2010; 45: 399–405.

31. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8–15.

32. Lafferty L, Tuohy M, Carey A, et al. Outcomes of exclusive enteral nutrition in paediatric Crohn’s disease. Eur J Clin Nutr 2017; 71: 185–191.

33. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. In: Zachos M (ed). Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd, 2007, CD000542.

34. Buchanan E, Gaunt WW, Cardigan T, et al. The use of exclusive enteral nutrition for induction of remission in children with Crohn’s disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 2009; 30: 501–507.

35. Afzal NA, Davies S, Paintin M, et al. Colonic Crohn’s disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 2005; 50: 1471–1475.

36. Johnson T, Macdonald S, Hill SM, et al. Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006; 55: 356–361.

37. Kaakoush NO, Day AS, Leach ST, et al. Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn’s disease. Clin Transl Gastroenterol 2015; 6: e71.

38. Grogan JL, Casson DH, Terry A, et al. Enteral feeding therapy for newly diagnosed pediatric Crohn’s disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis 2012; 18: 246–253.

39. Rubio A, Pigneur B, Garnier-Lengliné H, et al. The efficacy of exclusive nutritional therapy in paediatric Crohn’s disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011; 33: 1332–1339.

40. Faiman A, Mutalib M, Moylan A, et al. Standard versus rapid food reintroduction after exclusive enteral nutritional therapy in paediatric Crohn’s disease. Eur J Gastroenterol Hepatol 2014; 26: 276–281.

41. Grogan JL, Casson DH, Terry A, et al. Enteral feeding therapy for newly diagnosed pediatric Crohn’s disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis 2012; 18: 246–253.

42. Kim HJ, Kim Y, Cho JM, et al. Therapeutic efficacy of oral enteral nutrition in pediatric Crohn’s disease: A single center non-comparative retrospective study. Yonsei Med J 2016; 57: 1185.

43. Yamamoto T, Nakahigashi M, Saniabadi AR, et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm Bowel Dis 2007; 13: 1493–1501.

44. Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: A prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2007; 25: 67–72.

45. Duncan H, Buchanan E, Cardigan T, et al. A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing! BMC Gastroenterol 2014; 14: 50.

46. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an “half elemental diet” as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther 2006; 24: 1333–1340.

47. Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology 2017; 152: 398–414